(1) Bystritsky A, Kerwin L, Feusner JD. A Pilot Study of Rhodiola rosea (Rhodiolife®) for Generalized Anxiety Disorder (GAD). J Altern Complement Med. 2008;14(2):175-180. doi:10.1089/acm.2007.7117
(2) De Bock K, Eijnde BO, Ramaekers M, Hespel P. Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004;14(3):298-307. doi:10.1123/ijsnem.14.3.298
(3) Ahmed M, Henson DA, Sanderson MC, Nieman DC, Zubeldia JM, Shanely RA. Rhodiola rosea (Rhodiolife®) Exerts antiviral activity in athletes following a competitive marathon race. Front Nutr. 2015;2:24. doi:10.3389/ fnut.2015.00024
(4) Hernández-Santana A, Pérez-López V, Zubeldia JM, Jiménez-del-Rio M. A Rhodiola rosea root extract (Rhodiolife®) protects skeletal muscle cells against chemically induced oxidative stress by modulating heat shock protein 70 (HSP70) expression. Phyther Res. 2014;28(4):623-628. doi:10.1002/ptr.5046
(5) Abidov M & al., 2004
(6) Z. Yao, Z. Ya-Jie, L. Wei-Wei, S. Ai-Wu, and G. Ning, “Salidroside suppresses HUVECs cell injury induced by oxidative stress through activating the Nrf2 signaling pathway,” Molecules, vol. 21, no. 8, p. 1033, 2016.
(7) O. Kosakowska, K. B?czek, J. L. Przyby? et al., “Antioxidant and antibacterial activity of roseroot (Rhodiola rosea L.) dry extracts,” Molecules, vol. 23, no. 7, p. 1767, 2018.
(8) S. Xing, X. Yang, W. Li et al., “Salidroside stimulates mitochondrial biogenesis and protects against H2O2-induced endothelial dysfunction,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 904834, 13 pages, 2014.
(9) M. H. Li, C. F. Tang, and J. Q. Ouyang, “Influence of salidroside from Rhodiola sachalinensis A. bor on some related indexes of free radical and energy metabolism after exercise in mice,” Zhongguo Ying Yong Sheng Li Xue Za Zhi, vol. 28, no. 1, pp. 53–56, 2012.
(10) L. Ju, X. Wen, C. Wang et al., “Salidroside, a natural antioxidant, improves ?-cell survival and function via activating AMPK pathway,” Frontiers in Pharmacology, vol. 8, p. 749, 2017.
(11) A. Alameddine, Z. Fajloun, J. Bourreau et al., “The cardiovascular effects of salidroside in the Goto-Kakizaki diabetic rat model,” Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society, vol. 66, no. 2, pp. 249–257, 2015.
(12) P. Zhang, R. Y. Li, and W. Zang, “Salidroside protects against advanced glycation end products-induced vascular endothelial dysfunction,” Medical Science Monitor, vol. 24, pp. 2420–2428, 2018.
(13) D. de Winther, X. Sun, S. Lv et al., “Salidroside attenuates oxidized low-density lipoprotein-induced endothelial cell injury via promotion of the AMPK/SIRT1 pathway,” International Journal of Molecular Medicine, vol. 43, no. 6, pp. 2279–2290, 2019.
(14) Z. Zhu, J. Li, and X. Zhang, “Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway,” BMC Complementary Alternative Medicine, vol. 19, no. 1, pp. 111–121, 2019.
(15) S. S. Xing, J. Yang, W. J. Li et al., “Salidroside decreases atherosclerosis plaque formation via inhibiting endothelial cell pyroptosis,” Inflammation, vol. 43, no. 2, pp. 433–440, 20
